Shuai Sun Selected Research

ginsenoside Ro

1/2021

Ginsenoside Ro Ameliorates High-Fat Diet-Induced Obesity and Insulin Resistance in Mice via Activation of the G Protein-Coupled Bile Acid Receptor 5 Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuai Sun Research Topics

Disease

21	Neoplasms (Cancer) 07/2022 - 09/2015
10	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2022 - 08/2012
7	Squamous Cell Carcinoma of Head and Neck 12/2019 - 01/2018
6	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2018
4	Endometriosis 07/2022 - 01/2021
4	Carcinogenesis 01/2019 - 01/2018
3	Body Weight (Weight, Body) 01/2021 - 05/2018
2	Infertility (Sterility) 07/2022 - 01/2021
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2018
2	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 01/2022
2	Lymphatic Metastasis 01/2022 - 01/2020
2	Infections 12/2021 - 11/2019
2	Supraventricular Tachycardia 04/2021 - 01/2020
2	Obesity 01/2021 - 07/2019
2	Triploidy 02/2016 - 01/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2022
1	Endometrioid Carcinoma 07/2021
1	Transient Global Amnesia 04/2021
1	Amnesia (Dissociative Amnesia) 04/2021
1	Heart Failure 01/2021
1	Insulin Resistance 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Growth Hormone-Secreting Pituitary Adenoma 12/2020
1	Endometrial Stromal Sarcoma 01/2020
1	Primitive Neuroectodermal Tumors (PNET) 01/2020
1	Rectal Neoplasms (Rectal Cancer) 01/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2019
1	Lung Neoplasms (Lung Cancer) 07/2019
1	Inflammation (Inflammations) 07/2019
1	Type 2 Diabetes Mellitus (MODY) 07/2019
1	Germinoma 03/2019
1	Mouth Neoplasms (Oral Cancer) 01/2019
1	Liver Neoplasms (Liver Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

7	Circular RNAIBA 12/2019 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2015
3	Biological ProductsIBA 11/2019 - 10/2012
2	RNA (Ribonucleic Acid)IBA 06/2022 - 02/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 09/2017
2	Hormones (Hormone)IBA 11/2021 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2015
2	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 07/2019
2	LipidsIBA 01/2021 - 07/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2022
1	Peroxynitrous Acid (Peroxynitrite)IBA 07/2022
1	Chelating AgentsIBA 07/2022
1	Vitamin E FDA LinkGeneric 07/2022
1	Deferoxamine (Desferal)FDA LinkGeneric 07/2022
1	IronIBA 07/2022
1	Polysaccharides (Glycans)IBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Pharmaceutical PreparationsIBA 12/2021
1	alpha-Linolenic Acid (Linolenic Acid)IBA 10/2021
1	GTP-Binding Proteins (G-Protein)IBA 01/2021
1	ginsenoside RoIBA 01/2021
1	oleananeIBA 01/2021
1	Sirtuin 1IBA 01/2021
1	Caspase 3 (Caspase-3)IBA 01/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021
1	Vascular Endothelial Growth Factor CIBA 01/2021
1	GinsenosidesIBA 01/2021
1	granuloseIBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Insulin-Like Growth Factor I (IGF-1)IBA 12/2020
1	Antimicrobial Cationic PeptidesIBA 01/2020
1	Small Interfering RNA (siRNA)IBA 11/2019
1	squamous cell carcinoma-related antigenIBA 11/2019
1	CaspasesIBA 11/2019
1	Untranslated RNA (Noncoding RNA)IBA 11/2019
1	Phospholipases A2 (Phospholipase A2)IBA 07/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2019
1	EnzymesIBA 07/2019
1	Thyroxine (Levothyroxine)FDA LinkGeneric 07/2019
1	Psyllium (Metamucil)IBA 07/2019
1	ceramide glucosyltransferaseIBA 07/2019
1	Inositol (Myoinositol)IBA 07/2019
1	Long Noncoding RNAIBA 01/2019
1	Finasteride (Propecia)FDA LinkGeneric 05/2018
1	Saline SolutionIBA 05/2018
1	PlatinumIBA 01/2018
1	Adenosine Diphosphate (ADP)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 01/2018

Therapy/Procedure

14	Radiotherapy 01/2022 - 08/2012
8	Drug Therapy (Chemotherapy) 01/2022 - 09/2015
6	Therapeutics 01/2022 - 09/2017
5	Brachytherapy 01/2022 - 11/2017
4	Chemoradiotherapy 12/2019 - 08/2017
3	Adjuvant Radiotherapy 01/2022 - 01/2020
2	Immunotherapy 01/2022 - 01/2018
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 12/2020 - 01/2020
1	Catheter Ablation 04/2021
1	Radiofrequency Ablation 04/2021
1	Emergency Treatment 01/2020
1	Electric Countershock (Cardioversion) 01/2020
1	Neoadjuvant Therapy 01/2020
1	Craniospinal Irradiation 03/2019
1	Duration of Therapy 11/2018